Browse the latest research summaries in the field of pain management for spinal cord injury patients and caregivers.
Showing 71-80 of 682 results
PNAS, 2022 • November 2, 2022
This study identifies Tmem45b as a crucial molecule for inflammation- and tissue injury-induced mechanical pain hypersensitivity. Tmem45b is mainly expressed in IB4+ sensory neurons. Tmem45b-knockout ...
KEY FINDING: IB4+ sensory neurons are selectively involved in inflammation- and tissue injury–induced mechanical pain hypersensitivity, but not in neuropathic pain.
Journal of Pain Research, 2022 • October 25, 2022
Our study suggests that CONPs can relive the NP following SCI by promoting M2 macrophages polarization, which provides a novel insight for the treatment of SCI induced NP. Many researchers in the SCI ...
KEY FINDING: The synthesized CONPs were 6.8 ± 0.5 nm in size, presenting a cubic morphology.
PNAS, 2022 • November 7, 2022
This study investigates the role of spinal neuropeptide Y Y1 receptor-expressing neurons (Y1-INs) in neuropathic pain. The researchers found that nerve injury increases the excitability of Y1-INs, lea...
KEY FINDING: Spared nerve injury (SNI) enhances the excitability of Y1-INs and elicits allodynia and affective pain.
PHARMACEUTICAL BIOLOGY, 2022 • November 21, 2022
This study investigates the therapeutic potential of veratramine for diabetic peripheral neuropathy (DPN) using a rat model. The results showed that veratramine effectively alleviates pain symptoms as...
KEY FINDING: Veratramine significantly increased the mechanical withdrawal threshold in DPN rats, indicating reduced pain sensitivity.
Korean J Neurotrauma, 2022 • October 18, 2022
This case report describes a patient who developed posterior cord syndrome, characterized by decreased proprioception, immediately after spinal cord stimulation (SCS) electrode lead insertion for chro...
KEY FINDING: The patient developed posterior cord syndrome, specifically a loss of proprioception, immediately after the insertion of a paddle-type SCS electrode lead.
Heliyon, 2024 • June 13, 2024
The study aimed to verify the analgesic effect of intravenous administration of human umbilical cord mesenchymal stem cells (HUC-MSCs) upon rats with chronic constriction injury (CCI)-induced neuropat...
KEY FINDING: Intravenous administration of HUC-MSCs significantly ameliorated CCI-induced mechanical allodynia and thermal hyperalgesia in rats.
Int. J. Mol. Sci., 2022 • November 18, 2022
The study aimed to investigate the role of H4R in the anti-hyperalgesic action of the H3R antagonist GSK189254 in the spared nerve injury (SNI) model in mice. The results showed that GSK189254 attenua...
KEY FINDING: GSK189254 reversed mechanical and thermal allodynia in SNI mice, but this effect was prevented by blocking H4R with JNJ 10191584.
British Journal of Anaesthesia, 2023 • November 24, 2022
This study examined the effect of intrathecal injection of NIS-lncRNA antisense oligonucleotides on neuropathic pain caused by chronic constriction injury (CCI) of the sciatic nerve, spinal nerve liga...
KEY FINDING: Intrathecal NIS-lncRNA antisense oligonucleotides attenuated CCI-induced mechanical allodynia, heat hyperalgesia, cold hyperalgesia, and ongoing nociceptive responses, without changing basal or acute nociceptive responses and locomotor function.
Journal of Translational Medicine, 2022 • November 17, 2022
The study reveals a novel role of the C/EBPβ-Clec7a axis in neuropathic pain progression, indicating that CCI-induced overexpression of Clec7a and the direct interaction between C/EBPβ and Clec7a alon...
KEY FINDING: Clec7a is significantly upregulated in spinal cord tissues of rats with chronic constriction injury (CCI), a model for neuropathic pain.
Neural Plasticity, 2022 • October 19, 2022
This study investigated the effect of exercise on neuropathic pain in mice with spared nerve injury (SNI). The researchers examined pain behavior and molecular changes in the spinal cord. The study fo...
KEY FINDING: Spared nerve injury (SNI) led to mechanical and cold allodynia, elevated expression of latency-associated peptide- (LAP-) TGF-β1, and activated astroglial in the spinal cord.